Detalhe da pesquisa
1.
Effects of Early Short-Course Corticosteroids on Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.
Oncology
; 102(4): 318-326, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-37778345
2.
Cross-site validation of lung cancer diagnosis by electronic nose with deep learning: a multicenter prospective study.
Respir Res
; 25(1): 203, 2024 May 10.
Artigo
Inglês
| MEDLINE | ID: mdl-38730430
3.
Real-world evidence of lorlatinib therapy in Taiwanese patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer.
J Formos Med Assoc
; 2024 Jan 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38195317
4.
Different treatment efficacies and T790M acquisition of EGFR-TKIs on NSCLC patients with variable Del-19 subtypes of EGFR.
Int J Cancer
; 153(2): 352-363, 2023 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36912241
5.
LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis.
J Biomed Sci
; 30(1): 80, 2023 Sep 19.
Artigo
Inglês
| MEDLINE | ID: mdl-37726723
6.
Lung adenocarcinoma with neuroendocrine differentiation: Molecular markers testing and treatment outcomes.
J Formos Med Assoc
; 122(8): 731-737, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-36586785
7.
Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG).
Oncologist
; 27(4): 255-265, 2022 04 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35274704
8.
Assessing tumor angiogenesis using dynamic contrast-enhanced integrated magnetic resonance-positron emission tomography in patients with non-small-cell lung cancer.
BMC Cancer
; 21(1): 348, 2021 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33794813
9.
Efficacy and Safety of Cone-Beam Computed Tomography-Derived Augmented Fluoroscopy Combined with Endobronchial Ultrasound in Peripheral Pulmonary Lesions.
Respiration
; 100(6): 538-546, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33845482
10.
Detecting small pulmonary nodules with spiral ultrashort echo time sequences in 1.5 T MRI.
MAGMA
; 34(3): 399-409, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-32902778
11.
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations.
Int J Clin Oncol
; 26(5): 841-850, 2021 May.
Artigo
Inglês
| MEDLINE | ID: mdl-33783657
12.
Ramucirumab or placebo plus erlotinib in EGFR-mutated, metastatic non-small-cell lung cancer: East Asian subset of RELAY.
Cancer Sci
; 111(12): 4510-4525, 2020 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-32954593
13.
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib.
Oncologist
; 25(8): 702-711, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32386255
14.
Clinical factors associated with treatment toxicity of pemetrexed plus platinum in elderly patients with non-small cell lung cancer.
J Formos Med Assoc
; 119(10): 1506-1513, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-31917064
15.
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 20(12): 1655-1669, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31591063
16.
Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer.
Int J Cancer
; 145(6): 1609-1624, 2019 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31162839
17.
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations.
Int J Cancer
; 144(11): 2887-2896, 2019 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30485437
18.
Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors.
Oncologist
; 24(12): e1417-e1425, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31127020
19.
Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: a case-control observational study.
BMC Cancer
; 19(1): 1006, 2019 Oct 26.
Artigo
Inglês
| MEDLINE | ID: mdl-31655564
20.
Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion.
Genes Chromosomes Cancer
; 57(10): 513-521, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-30107055